Defining minimal detectable difference in echocardiographic measures of right ventricular function in systemic sclerosis
Abstract
Echocardiography (2DE) is integral for screening and longitudinal evaluation of pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc). In the present study, we sought to establish the reliability, repeatability, and reproducibility of 2DE parameters in SSc patients with and without PAH and to define the minimal detectable difference (MDD), the smallest change detected beyond measurement error.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 18, 2022
- Source ID
- 10.1186/s13075-022-02835-5
Entities
People
- Ami A Shah
- Aparna Balasubramanian
- Catherine E. Simpson
- Monica Mukherjee
- Paul M. Hassoun
- Rachel Damico
- Stephen C. Mathai
- Steven Hsu
- Todd M. Kolb
- Valentina Mercurio
Organizations
- Johns Hopkins University
- MSD (United Kingdom)
- National Heart, Lung, and Blood Institute
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Scleroderma Foundation
- United States Department of Defense